Sourced from SA
This article is an update to a previous Oxford Square Capital (OXSQ) article returning to the chronic issue of Oxford’s underlying investment strategy in collateralized loan obligations (“CLOs”). In review, Oxford Square Capital is a business development company (“BDC”) labeled investment firm that invests in loans and CLO investments. Since COVID-19, the stock has seen a dramatic 45% decline in its stock price from $6.21 to $3.33. These declines follow the 35% declines in net asset value per share (“NAVPS”) for the company from $5.12 at the end of 2019 fiscal year